- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More
| Stock | Company | % Portfolio | Shares Held | Market Value | Change in Shares | % Change | Quarter End Price | Source |
|---|---|---|---|---|---|---|---|---|
| TRVI | Trevi Therapeutics Inc | 8.68% | 5,094,668 | $95,015,558 | No Change | $18.65 | 13F | |
| PRAX | Praxis Precision Medicines | 8.29% | 271,116 | $90,766,926 | -67,779 | -20% | $334.79 | 13F |
| ERAS | Erasca Inc | 6.9% | 4,127,412 | $75,614,188 | -8,024,068 | -66.03% | $18.32 | 13F |
| AVBP | Arrivent BioPharma Inc | 5.34% | 1,682,097 | $58,436,050 | 796,181 | 89.87% | $34.74 | 13F |
| ABVX | Abivax SA - ADR | 5.05% | 414,899 | $55,289,441 | 175,360 | 73.21% | $133.26 | 13F |
| TNGX | Tango Therapeutics Inc | 3.94% | 1,379,769 | $43,131,579 | -775,011 | -35.97% | $31.26 | 13F |
| CRVS | Corvus Pharmaceuticals Inc | 3.83% | 2,805,816 | $41,918,891 | No Change | $14.94 | 13F | |
| DRUG | Bright Minds Biosciences Inc | 3.57% | 557,172 | $39,113,474 | No Change | $70.2 | 13F | |
| SVA | Sinovac Biotech Ltd. | 3.49% | 5,903,000 | $38,192,410 | No Change | $6.47 | 13F | |
| TENX | Tenax Therapeutics Inc | 3.32% | 2,500,000 | $36,375,000 | 2,291,667 | 1100% | $14.55 | 13F |
| ACRS | Aclaris Therapeutics, Inc. | 3.23% | 6,694,637 | $35,414,630 | 27,971 | 0.42% | $5.29 | 13F |
| DYN | Dyne Therapeutics Inc | 3.16% | 1,557,466 | $34,591,320 | No Change | $22.21 | 13F | |
| DNTH | Dianthus Therapeutics Inc | 3.15% | 353,998 | $34,507,725 | No Change | $97.48 | 13F | |
| ANRO | Alto Neuroscience Inc | 2.91% | 1,208,858 | $31,901,763 | 173,307 | 16.74% | $26.39 | 13F |
| DBVT | DBV Technologies SA | 2.76% | 1,844,758 | $30,254,031 | -822,811 | -30.84% | $16.4 | 13F |
| SABS | SAB Biotherapeutics Inc | 2.6% | 7,299,909 | $28,469,645 | -4,120,091 | -36.08% | $3.9 | 13F |
| MLTX | Moonlake Immunotherapeutics | 2.49% | 1,400,000 | $27,258,000 | 400,000 | 40% | $19.47 | 13F |
| LBRX | LB Pharmaceuticals Inc | 2.37% | 800,000 | $25,964,000 | No Change | $32.46 | 13F | |
| NERV | Minerva Neurosciences Inc | 2.19% | 4,322,747 | $23,991,246 | No Change | $5.55 | 13F | |
| DSGN | Design Therapeutics Inc | 2.13% | 1,612,903 | $23,338,706 | No Change | $14.47 | 13F | |
| ORIC | Oric Pharmaceuticals Inc | 1.83% | 1,848,786 | $20,022,352 | No Change | $10.83 | 13F | |
| CAMP | CAMP4 Therapeutics Corporation | 1.69% | 4,246,568 | $18,557,502 | No Change | $4.37 | 13F | |
| FTH | Faeth Therapeutics Inc | 1.65% | 722,020 | $18,050,500 | No Change | $25 | 13F | |
| ACHV | Achieve Life Sciences Inc. | 1.64% | 2,751,032 | $17,964,239 | 2,751,032 | New | $6.53 | 13F |
| CMPX | Compass Therapeutics Inc | 1.55% | 7,757,060 | $16,987,961 | -1,788,406 | -18.74% | $2.19 | 13F |
| ANTX | AN2 Therapeutics Inc | 1.39% | 3,153,640 | $15,263,618 | No Change | $4.84 | 13F | |
| EDIT | Editas Medicine Inc | 1.05% | 3,555,250 | $11,519,010 | 3,555,250 | New | $3.24 | 13F |
| GERN | Geron Corp | 1.01% | 8,671,797 | $11,099,900 | No Change | $1.28 | 13F | |
| ODTX | Odyssey Therapeutics Inc | 0.98% | 575,000 | $10,758,250 | 575,000 | New | $18.71 | 13F |
| EPRX | Eupraxia Pharmaceuticals Inc | 0.81% | 1,350,000 | $8,923,500 | No Change | $6.61 | 13F | |
| OKUR | Onkure Therapeutics Inc | 0.8% | 1,927,710 | $8,790,358 | No Change | $4.56 | 13F | |
| MNPR | Monopar Therapeutics Inc | 0.77% | 90,500 | $8,379,395 | No Change | $92.59 | 13F | |
| OLMA | Olema Pharmaceuticals Inc | 0.77% | 671,843 | $8,404,756 | No Change | $12.51 | 13F | |
| AURA | Aura Biosciences Inc | 0.76% | 1,166,667 | $8,283,336 | 1,166,667 | New | $7.1 | 13F |
| SRZN | Surrozen Inc | 0.62% | 260,000 | $6,747,000 | No Change | $25.95 | 13F | |
| ALXO | ALX Oncology Holdings Inc | 0.6% | 3,184,713 | $6,592,356 | No Change | $2.07 | 13F | |
| MSLE | Satellos Bioscience Inc | 0.58% | 813,666 | $6,326,253 | No Change | $7.77 | 13F | |
| AVTX | Avalo Therapeutics Inc | 0.46% | 275,000 | $5,082,000 | 275,000 | New | $18.48 | 13F |
| PEPG | Pepgen Inc | 0.38% | 2,325,000 | $4,185,000 | No Change | $1.8 | 13F | |
| VALN | Valneva SE | 0.36% | 763,199 | $3,991,531 | 763,199 | New | $5.23 | 13F |
| SERA | Sera Prognostics Inc | 0.27% | 1,650,440 | $3,003,801 | No Change | $1.82 | 13F | |
| UNCY | Unicycive Therapeutics | 0.24% | 550,000 | $2,579,500 | -1,239,916 | -69.27% | $4.69 | 13F |
| TIL | Instil Bio Inc | 0.21% | 292,743 | $2,251,194 | No Change | $7.69 | 13F | |
| INM | InMed Pharmaceuticals Inc | 0.11% | 798,377 | $1,237,484 | 798,377 | New | $1.55 | 13F |
| BOLT | Bolt Biotherapeutics Inc | 0.03% | 72,414 | $278,794 | No Change | $3.85 | 13F | |
| KTTA | Pasithea Therapeutics Corp | 0.02% | 465,471 | $239,904 | -1,634,529 | -77.83% | $0.52 | 13F |
| DTIL | Precision Biosciences Inc | 0.00336% | 4,675 | $36,746 | No Change | $7.86 | 13F | |
| COGT | Cogent Biosciences Inc | -422,300 | Exited | 13F | ||||
| CMPS | Compass Pathway PLC | -200,000 | Exited | 13F | ||||
| SLNO | Soleno Therapeutics Inc | -294,909 | Exited | 13F | ||||
| TERN | Terns Pharmaceuticals Inc | -1,334,418 | Exited | 13F | ||||
| MANE | Veradermics Inc | -300,000 | Exited | 13F | ||||
| VRDN | Viridian Therapeutics Inc | -166,288 | Exited | 13F |